Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost

Impact · against what's priced in

Clover Health's transition of Counterpart Health from an internal tool to a B2B clinical operating system provides a tangible path toward scaling revenue beyond its Medicare Advantage plan. The successful adoption by hundreds of third-party clinicians and new clinical validation for chronic disease management increase the company's valuation potential via a higher TAM.

CLOV+0.60

No priced-in read yet